Orgenesis Inc logo

Orgenesis Inc

NAS:ORGS (USA)  
$ 0.85 -0.0011 (-0.13%) 11:08 PM EST
At Loss
P/B:
2.07
Market Cap:
$ 29.03M
Enterprise V:
$ 50.76M
Volume:
15.41K
Avg Vol (2M):
161.65K
Also Trade In:
Volume:
15.41K
At Loss
Avg Vol (2M):
161.65K

Business Description

Description
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Morgenesis and Therapies.
Name Current Vs Industry Vs History
Equity-to-Asset 0.27
Debt-to-Equity 1.75
Debt-to-EBITDA -1.3
Altman Z-Score -4.72
Distress
Grey
Safe
Beneish M-Score 1.25
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 45.05
9-Day RSI 56.61
14-Day RSI 61.7
6-1 Month Momentum % -3.21
12-1 Month Momentum % -56.2

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.61
Quick Ratio 0.61
Days Inventory 1.23
Days Sales Outstanding 257.1
Days Payable 66.74

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -16.5
Shareholder Yield % -24.34

Financials (Next Earnings Date:2024-05-10 Est.)

ORGS's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ORGS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Orgenesis Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 27.753
EPS (TTM) ($) -0.9
Beta 0.87
Volatility % 139.67
14-Day RSI 61.7
14-Day ATR ($) 0.071534
20-Day SMA ($) 0.830075
12-1 Month Momentum % -56.2
52-Week Range ($) 0.25 - 1.5
Shares Outstanding (Mil) 34.15

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Orgenesis Inc Filings

Filing Date Document Date Form
No Filing Data

Orgenesis Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Orgenesis Inc Frequently Asked Questions

What is Orgenesis Inc(ORGS)'s stock price today?
The current price of ORGS is $0.85. The 52 week high of ORGS is $1.50 and 52 week low is $0.25.
When is next earnings date of Orgenesis Inc(ORGS)?
The next earnings date of Orgenesis Inc(ORGS) is 2024-05-10 Est..
Does Orgenesis Inc(ORGS) pay dividends? If so, how much?
Orgenesis Inc(ORGS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1